A recent Phase III clinical trial focused on gout patients who were intolerant or contraindicated to xanthine oxidase inhibitors (XOIs) revealed that lesinurad monotherapy at a dosage of 400 mg led to a significant incidence of elevated serum creatinine
Optimal dosing, timing, route of administration, and duration of treatment for human bone healing have not been established for investigational peptides
Therefore, a defensible identity package should specify the E/Z configuration and include NMR, chromatographic, and mass-spectrometric evidence
June 24, 2026 Sleep disruption is not simply a lifestyle inconve
Auguste says a patient is unlikely to develop toxicity, as experienced by the 54-year-old man, if theyre taking less than 4,000 IU daily